Literature DB >> 16915561

Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography/single quadrupole mass spectrometry.

Luciano Maestri1, Sara Negri, Massimo Ferrari, Sergio Ghittori, Francesca Fabris, Paolo Danesino, Marcello Imbriani.   

Abstract

A method is described that permits the measurement of the levels of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in human liver, kidney, adipose tissue, brain, basal ganglia, hypophysis, thyroid, gonads, pancreas, lung, skeletal muscle and blood, even in subjects not occupationally exposed to these compounds. The purification of samples involved the use of trifunctional (tC18) and strong anion-exchange (SAX) solid-phase extraction cartridges, and the analysis utilized a high-performance liquid chromatograph coupled to a single quadrupole mass spectrometer (LC/MS). The analyses were conducted on a mixed-bed reversed-phase column by gradient runs using 3 mM ammonium acetate/methanol mixtures at different proportions as the mobile phase. The detector was used in electrospray negative ion mode by recording simultaneously the ions m/z 413.0 (PFOA) and 499.0 (PFOS). Perfluorononanoic acid (PFNA), added to the samples before the purification, was used as the internal standard (ion monitored = m/z 463.6). The recovery rates of the extraction procedure ranged from 79.6 to 95.6% (CV% 1.7-7.4%) for PFOA, from 79.7 to 100.8% (CV% = 1.2-7.1) for PFOS, and from 89.1 to 102.3% (CV% = 0.9-5.2 %) for PFNA. The calibration curves were linear up to at least 400 ng of analytes per gram of tissue. The detection limits (signal-to-noise ratio = 3) were 0.1 ng/g for both PFOA and PFOS measured in all tissues except adipose tissue, where the limits were about 0.2 ng/g. The content of analytes in tissues varied from 0.3 to 3.8 ng/g (respectively: basal ganglia and lung) for PFOA, and from 1.0 to 13.6 ng/g (respectively: skeletal muscle and liver) for the linear isomer of PFOS. The method is suitable to evaluate the content of PFOA and PFOS in different tissues taken from the general population exposed to very low concentrations of these pollutants. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16915561     DOI: 10.1002/rcm.2661

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  35 in total

1.  Environmental and biological monitoring of persistent fluorinated compounds in Japan and their toxicities.

Authors:  Kouji H Harada; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2008-11-11       Impact factor: 3.674

2.  Na+/Taurocholate Cotransporting Polypeptide and Apical Sodium-Dependent Bile Acid Transporter Are Involved in the Disposition of Perfluoroalkyl Sulfonates in Humans and Rats.

Authors:  Wen Zhao; Jeremiah D Zitzow; David J Ehresman; Shu-Ching Chang; John L Butenhoff; Jameson Forster; Bruno Hagenbuch
Journal:  Toxicol Sci       Date:  2015-05-21       Impact factor: 4.849

3.  Embryonic exposures to perfluorooctanesulfonic acid (PFOS) disrupt pancreatic organogenesis in the zebrafish, Danio rerio.

Authors:  Karilyn E Sant; Haydee M Jacobs; Katrina A Borofski; Jennifer B Moss; Alicia R Timme-Laragy
Journal:  Environ Pollut       Date:  2016-10-31       Impact factor: 8.071

4.  Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women.

Authors:  Emily S Barrett; Chongshu Chen; Sally W Thurston; Line Småstuen Haug; Azemira Sabaredzovic; Frøydis Nyborg Fjeldheim; Hanne Frydenberg; Susan F Lipson; Peter T Ellison; Inger Thune
Journal:  Fertil Steril       Date:  2015-03-04       Impact factor: 7.329

Review 5.  Impact of perfluorochemicals on human health and reproduction: a male's perspective.

Authors:  C Foresta; S Tescari; A Di Nisio
Journal:  J Endocrinol Invest       Date:  2017-11-17       Impact factor: 4.256

6.  Exposure to perfluorinated compounds: in vitro study on thyroid cells.

Authors:  Francesca Coperchini; Patrizia Pignatti; Serena Lacerenza; Sara Negri; Riccardo Sideri; Claudia Testoni; Luca de Martinis; Danilo Cottica; Flavia Magri; Marcello Imbriani; Mario Rotondi; Luca Chiovato
Journal:  Environ Sci Pollut Res Int       Date:  2014-09-04       Impact factor: 4.223

Review 7.  Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA).

Authors:  F Coperchini; O Awwad; M Rotondi; F Santini; M Imbriani; L Chiovato
Journal:  J Endocrinol Invest       Date:  2016-11-11       Impact factor: 4.256

8.  Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor.

Authors:  Manhai Long; Mandana Ghisari; Eva Cecilie Bonefeld-Jørgensen
Journal:  Environ Sci Pollut Res Int       Date:  2013-03-29       Impact factor: 4.223

9.  Biomonitoring perfluorinated compounds in Catalonia, Spain: concentrations and trends in human liver and milk samples.

Authors:  Anna Kärrman; José L Domingo; Xavier Llebaria; Martí Nadal; Esther Bigas; Bert van Bavel; Gunilla Lindström
Journal:  Environ Sci Pollut Res Int       Date:  2009-05-21       Impact factor: 4.223

10.  Interaction of perfluorooctanoic acid with human serum albumin.

Authors:  Ling-Ling Wu; Hong-Wen Gao; Nai-Yun Gao; Fang-Fang Chen; Ling Chen
Journal:  BMC Struct Biol       Date:  2009-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.